COMBRETASTATIN DERIVATIVES AND USES THEREFOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120309734A1
SERIAL NO

13515555

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Cancer is one of the major causes of death worldwide. Although many advances have been made in the treatment and management of the disease, the existence of chemotherapy-resistance means there is still a great need to develop new strategies and drugs for its treatment. Provided herein are synthetic derivatives of combretastatin A-4, in particular those in which the aromatic rings are locked into a non-isomerisable active conformation, thus resulting in improved, stable compounds. The novel compounds are structurally related to combretastatin A-4 (CA-4) and lock the rings into the known active conformation by means of a four membered nitrogen containing heterocyclic ring, such as a beta-lactam ring, incorporated into the standard CA-4 structure. The compounds exhibit potent anti-cancer activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINCOLLEGE GREEN DUBLIN 2 DUBLIN IRELAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carr, Miriam Kilmallock, IE 2 0
Greene, Lisa Dublin, IE 2 0
Greene, Thomas Tipperary, IE 13 701
Meegan, Mary J Dublin, IE 1 0
O'Boyle, Niamh Newbridge, IE 1 0
Zisterer, Daniela Bray, IE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation